Mabion SA
WSE:MAB
Mabion SA
Research & Development
Mabion SA
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mabion SA
WSE:MAB
|
Research & Development
-zł254k
|
CAGR 3-Years
72%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
R
|
Read Gene SA
WSE:RDG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Genomed SA
WSE:GEN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Bioton SA
WSE:BIO
|
Research & Development
-zł4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-3%
|
|
|
U
|
Urteste SA
WSE:URT
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Synthaverse SA
WSE:SVE
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mabion SA
Glance View
Mabion SA is a biotechnology company, which engages in the development and manufacture of biotech drugs. The company is headquartered in Konstantynow Lodzki, Woj. Lodzkie and currently employs 213 full-time employees. The company went IPO on 2010-08-10. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in biotechnology field, including BioCentrum Ltd and Biotech Consulting Ltd. The firm specializes in the humanized monoclonal antibodies (mAbs) technology, a new generation of biotechnological drugs. The company focuses on oncology drugs used to treat blood cancer, lymphomas and leukemias, rheumatoid arthrisis, as well as breast cancer. The company operates its own Research and Development Center in the Special Economical Zone in Lodz, Poland.
See Also
What is Mabion SA's Research & Development?
Research & Development
-254k
PLN
Based on the financial report for Sep 30, 2025, Mabion SA's Research & Development amounts to -254k PLN.
What is Mabion SA's Research & Development growth rate?
Research & Development CAGR 5Y
62%
Over the last year, the Research & Development growth was 86%. The average annual Research & Development growth rates for Mabion SA have been 72% over the past three years , 62% over the past five years .
